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INTRODUCTION
Although implant-based reconstruction is the most 
common approach to breast reconstruction,1,2 autologous 
reconstruction is also well established and is associated 
with increased patient satisfaction and quality of life.3 Of 
women who elect to undergo breast reconstruction fol-
lowing mastectomy, 13 percent had autologous recon-
struction using abdominally based tissue.13 This includes 
pedicled transverse rectus abdominis (pTRAM), free 
TRAM (fTRAM), and deep inferior epigastric (DIEP) flap 
reconstructions. With greater public concern surrounding 
implant-based reconstruction and recent FDA initiatives 
to explore breast implant safety,2,3 we anticipate a rise in 
autologous reconstruction in the near future. Thus, there 
exists a need to re-examine flap selection criteria based on 
contemporary literature.
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Introduction: Transverse rectus abdominis myocutaneous (TRAM) and deep inferior 
epigastric artery perforator (DIEP) flaps are the most common abdominally based 
breast reconstruction procedures. Each technique has its advantages and disadvan-
tages; however, how morbidity relates to satisfaction is not well-understood. Our aim 
was to compare complications and patient-reported outcomes following pedicled 
TRAM (pTRAM), free TRAM (fTRAM), and DIEP flaps to guide flap selection.
Methods: A systematic literature search was conducted, and 2 independent review-
ers identified comparative studies of abdominally based flaps. Data were extracted 
on patient characteristics, complications, and patient-reported outcomes. Meta-
analyses were conducted using random effects modeling with the DerSimonian 
and Laird method.
Results: The search retrieved 5090 articles, of which 18 were included in this 
review. pTRAM flaps trended toward a higher risk of abdominal bulge/hernia 
compared with DIEP flaps, particularly in low-volume hospitals. While fTRAM 
flaps had a higher risk of abdominal morbidity compared with DIEP flaps, relative 
risk decreased when obese patients were excluded and when only muscle-sparing 
fTRAM flaps were compared. Muscle-sparing flaps had a higher risk of flap loss 
than fTRAM flaps. Compared with DIEP flaps, pTRAM flaps were associated with 
lower general satisfaction but comparable emotional well-being.
Conclusions: Our findings indicate that safety and satisfaction following abdomi-
nally based breast reconstruction depend on flap type and patient characteristics. 
When possible, DIEP or muscle-sparing fTRAM flaps should be performed for obese 
patients to decrease the risk of abdominal bulge/hernia. Although pTRAM flaps 
are associated with a greater risk of flap loss, they are still an appropriate option 
when microsurgery is not available. (Plast Reconstr Surg Glob Open 2020;8:e3120; doi: 
10.1097/GOX.0000000000003120; Published online 29 October 2020.)
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Previous studies show that DIEP and muscle-sparing 
(MS) fTRAM flaps have a decreased incidence of abdomi-
nal bulge/hernia compared with pTRAM and non-mus-
cle-sparing fTRAM flaps, suggesting that harvesting less 
muscle results in better donor-site outcomes.4,5 DIEP flaps, 
while sparing abdominal rectus muscle, are associated 
with a higher rate of flap loss and fat necrosis, presumably 
from a less robust blood flow compared with the fTRAM 
flap and technical challenges of perforator dissection.6–8 
Despite these differences in complication rates, little is 
known regarding how postoperative morbidity correlates 
with patient-reported outcomes. While some surveys show 
no difference in patient satisfaction following DIEP and 
non-muscle-sparing fTRAM flaps,9–12 there is less literature 
comparing DIEP flaps to MS fTRAM or pTRAM flaps.
Additionally, because most flap selection criteria rely 
on intraoperative indications or conventional recommen-
dations based on patient characteristics, the relationship 
between preoperative risk factors and complications for 
abdominally based flap reconstruction remains unclear. 
In particular, while obesity and lower hospital procedural 
volume status have been shown to lead to overall higher 
risk of postoperative morbidity,13–19 impact on safety out-
comes has not yet been summarized according to abdomi-
nally based flap type.
To our knowledge to date, a systematic review and 
meta-analysis comparing complications and quality of life 
for all major abdominally based breast reconstruction 
techniques, and assessing the impact of preoperative risk 
factors, have not yet been performed.4–6,16 An improved 
understanding of these outcomes is critical so that patients 
and providers can have informed discussions about expec-
tations for recovery during the shared decision-making 
process. The aim of this study was to compare safety and 
patient-reported outcomes following pedicled (pTRAM), 
free TRAM (fTRAM), and DIEP flaps, as well as to assess 
whether these differ on the basis of obesity and hospital 
procedural volume status, to guide optimal flap selection.
METHODS
Study Selection and Data Extraction
MEDLINE, EMBASE, the Cochrane Central Register 
of Controlled Trials, Web of Science, and Scopus were 
systematically queried for studies of breast reconstruc-
tion following mastectomy for cancer, according to our 
systematic review protocol (PROSPERO registration 
CRD42020147475). Covidence (Melbourne, Australia) 
was used to manage study selection, quality assessment, 
and data extraction. Study selection was based on pre-
defined eligibility criteria in a Population, Intervention, 
Comparison, Outcome, Timing, and Setting (PICOTS) 
framework (See appendix, Supplemental Digital Content 1, 
which displays a PICOTS (population, interventions, com-
parators, outcomes, timing, and setting) for the key ques-
tions. Appendix B. Risk of bias across included studies of 
complications and patient-reported outcomes. http://
links.lww.com/PRSGO/B491). Following PRISMA guide-
lines, 2 reviewers independently screened abstracts and 
full text articles to identify comparative studies of pedicled, 
free, and muscle-sparing free TRAM and DIEP flap breast 
reconstructions published after 2000. References of 
included studies were searched for additional relevant 
titles.
Two reviewers independently assessed the risk of 
bias for individual studies using the Risk of Bias in Non-
Randomised Studies of Interventions (ROBINS-I),20 and 
extracted data on general study characteristics, patient 
characteristics, and complications and patient-reported 
outcomes. Differences between reviewers at any stage were 
resolved through consensus.
Statistical Analysis
To standardize results, we conducted the meta-analyses 
for complications to reflect the authors’ definitions from 
each study. Hospital procedural volume was calculated 
as the number of abdominally-based autologous breast 
reconstructions performed per year during the study 
period, and institutions in the lower 50th percentile were 
classified as low-volume.
Meta-analyses for outcomes were conducted using a 
random effects model with the DerSimonian and Laird 
method when there were at least 2 sufficiently homoge-
neous studies. Associations between flap type (ie, pTRAM, 
fTRAM, and DIEP flaps) and complications were reported 
as effect sizes with 95% confidence intervals. A post-hoc 
sensitivity analysis was conducted using the Hartung-
Knapp-Sidik-Jonkman method. Subgroup analyses were 
conducted using flap subtypes (ie, MS fTRAM flaps) 
as well as patient- and hospital-level factors. A Haldane-
Anscombe correction was used for outcomes with small 
counts. All meta-analyses were conducted using Microsoft 
Excel (version 16).
RESULTS
The search retrieved 5090 unique articles, of which 
4132 were excluded during abstract screening and 940 
were excluded during full-text screening (Fig. 1). A total 
of 18 articles were ultimately included in this systematic 
review.9–14,21–32 Overall risk of bias was low for 5 and mod-
erate for 11 studies (see Supplemental Digital Content 
1, http://links.lww.com/PRSGO/B491). Fifteen arti-
cles assessed safety,9–11,13,14,21–30,32 and 8 provided patient-
reported outcomes (Table  1).9–12,14,25,31,32 All were cohort 
studies, with the exception of 1 cross-sectional study.31
Complications
Pooled estimates demonstrated a trend toward higher 
abdominal bulge/hernia rates (RR = 2.82, 95% CI = 0.83–
4.80) following pTRAM compared to DIEP flaps, which 
increased in a subgroup analysis with only low-volume hos-
pitals (RR = 3.08, 95% CI = 0.46–5.70) (Table 2). Similarly, 
there were trends toward higher relative risks of flap loss, 
mastectomy skin flap necrosis, fat necrosis, and wound 
healing complications following pTRAM compared with 
DIEP flaps in low-volume hospitals, although these did not 
reach statistical significance.
Patients undergoing fTRAM were 2.87 times more 
likely to experience abdominal bulge/hernia (95% 
CI = 1.73–4.00) than patients undergoing DIEP flap 
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reconstruction (Table 3). However, relative risk decreased 
to 2.35 when obese patients were excluded in a sub-
group analysis (95% CI = 1.49–3.21) and 2.55 when only 
MS fTRAM flaps were compared to DIEP flaps (95% 
CI = 1.42–3.67) (Fig. 2). DIEP flaps were associated with 
a greater risk of flap loss (ES = 2.67, 95% CI = 1.00–4.34) 
than fTRAM, although relative risk decreased (RR = 1.93, 
95% CI = 0.26–3.61) in a comparison of DIEP with only 
MS fTRAM flaps. Differences in mastectomy skin flap 
necrosis, fat necrosis, infection, hematoma/seroma, and 
wound healing complications after fTRAM and DIEP flap 
reconstructions did not reach statistical significance.
Only one study reported on the development of hyper-
trophic scarring and keloids. It was found that breast scars 
developed after 2.3% of DIEP flap reconstructions, while 
none developed after pedicled or free TRAM flap recon-
structions.10 A comparable, low rate of abdominal donor-
site scarring was seen after DIEP (1.4%), pedicled TRAM 
(1.3%), and free TRAM (1.1%) flap reconstructions.
Patient-reported Outcomes
Four articles reported on psychosocial outcomes;9,10,14,25 
4 on satisfaction outcomes;9,10,31,32 5 on physical well-being 
outcomes;9–12,14 and 1 on pain (Table 4).11 Studies used the 
BREAST-Q9,10 and Short Form-36 (SF-36)14,25 to measure 
psychosocial outcomes. In the Mastectomy Reconstruction 
Outcomes Consortium study, BREAST-Q psychosocial and 
sexual well-being scores in pTRAM and fTRAM groups 
were not significantly different from scores in the DIEP 
group at both the first and second year post-reconstruc-
tion after adjusting for covariates,10 and scores improved 
with time regardless of reconstruction approach. Similar 
conclusions were observed in another multi-institution 
study.9 Psychosocial and sexual well-being scores were also 
not significantly different between MS fTRAM and DIEP 
groups. In one study, patients receiving bilateral pTRAM 
had higher SF-36 energy and well-being scores compared 
with those receiving DIEP flaps (P < 0.05 and P = 0.06, 
respectively).25 In another study, there were minimal dif-
ferences in the SF-36 mental health composite score 
between MS fTRAM and DIEP flaps at long-term follow-
up.14 Although obese and non-obese patients had similar 
preoperative scores, the SF-36 mental health composite 
score improved in non-obese patients and worsened in 
obese patients (P = 0.02).
Two studies measured satisfaction through a 7-item 
questionnaire developed for the Michigan Breast 
Reconstruction Outcome Study ,31,32 and two studies mea-
sured satisfaction using the BREAST-Q.9,10 Momoh et al. 
demonstrated that recipients of DIEP flap reconstruc-
tion had significantly higher general satisfaction than 
recipients of pTRAM flap reconstruction (P = 0.04).32 This 
likelihood was even more pronounced in the bilateral 
DIEP group compared with the bilateral pTRAM group 
(P = 0.0095). In contrast, another study found that there were 
no significant differences in general satisfaction between 
pTRAM and DIEP groups.31 Both studies suggest similar 
aesthetic satisfaction rates across different approaches to 
reconstruction. Macadam et al. demonstrated that there 
was significantly higher satisfaction with long-term outcome 
in the DIEP group compared with the pTRAM group (P 
= 0.015) after controlling for patient characteristics.9 This 
finding did not reach significance when comparing fTRAM 
or MS fTRAM with DIEP flaps, and the difference in satis-
faction with breasts did not vary between pTRAM, fTRAM, 
and DIEP groups after 1 and 2 years.9,10
Physical outcomes were assessed by the BREAST-Q 
and SF-36. In one study, DIEP flap patients experienced 
Fig. 1. Summary of the study selection process, showing the included 18 unique articles.
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significantly higher abdominal physical well-being com-
pared with pTRAM flap patients after controlling for 
cofounders (P < 0.001).9 Differences did not reach signifi-
cance when comparing the DIEP flap to fTRAM and MS 
fTRAM flaps. Similarly, no differences in abdominal well-
being scores between MS fTRAM flaps and DIEP flaps were 
noted in another study.14 The Mastectomy Reconstruction 
Outcomes Consortium study showed higher abdomen-
specific scores for DIEP compared with both pTRAM 
and fTRAM flaps one year postoperatively (P = 0.078 and 
P = 0.051, respectively) and significantly higher scores 
two years postoperatively (P = 0.006 and P = 0.037) after 
controlling for laterality, although in all groups unad-
justed postoperative scores were lower than preopera-
tive scores.10 The Mastectomy Reconstruction Outcomes 
Consortium study demonstrated that unadjusted physical 
chest well-being decreased from preoperative to 1 week 
postoperatively in pTRAM, fTRAM, and DIEP groups, and 
did not return to baseline levels at 3 months (P < 0.001).12 
Multivariable analysis showed there was no significant 
difference in physical well-being of chest scores between 
groups at 1 year postoperatively.10 Interestingly, however, 
the pTRAM group reported significantly lower scores 
at 2 years postoperatively compared to the DIEP group 
(P = 0.04).
In one study, the SF-36 physical health composite score 
significantly improved over time for both unilateral and 
bilateral MS fTRAM and DIEP flaps (P < 0.05), although 
no significant differences were noted during a direct com-
parison of flap type or laterality.14 Obesity lead to a sig-
nificant worsening in the physical health composite score 
over time (P = 0.003), while scores improved in non-obese 
patients. In another study, no significant differences were 
found between fTRAM and DIEP groups for scores on 
the SF-36 physical functioning or physical role limitations 
scales.11 Patients also reported that they rarely suffered 
from postoperative abdominal pain for a mean duration 
of 1–3 months.
DISCUSSION
This review evaluates abdominally based autologous 
breast reconstruction techniques and provides updated 
Table 1. Summary of Included Studies
Year of 
Publication Author Country
Study  
Design Intervention Groups Compared Complications
Patient- 
reported  
Outcomes Comments
2002 Nahabedian 
et al.
United States Retrospective 
cohort
• Free TRAM (n = 118)
• DIEP (n = 17)
X   
2005 Nahabedian 
et al.
United States Retrospective 
cohort
• Muscle-sparing free TRAM (n = 89)
• DIEP (n = 88)
X   
2006 Bajaj et al. United States Retrospective 
cohort
• Muscle-sparing free TRAM (n = 124)
• DIEP (n = 35)
X   
2006 Garvey et al. United States Retrospective 
cohort
• Pedicled TRAM (n = 94)
• DIEP (n = 96)
X  Unilateral 
flaps
2007 Chen et al. United States Retrospective 
cohort
• Free TRAM (n = 114)
• DIEP (n = 29)
X   
2007 Schaverien 
et al.
United 
Kingdom
Retrospective 
cohort
• Free TRAM (n = 30)
• DIEP (n = 30)
X X Unilateral 
flaps
2010 Chun et al. United States Retrospective 
cohort
• Pedicled TRAM (n = 105)
• DIEP (n = 58)
X X Bilateral flaps
2010 Nelson et al. United States Retrospective 
cohort
• Muscle-sparing free TRAM (n = 91)
• DIEP (n = 53)
X   
2012 Momoh et al. United States Retrospective 
cohort
• Pedicled TRAM (n = 179)
• DIEP (n = 167)
X X  
2013 Fischer et al. United States Retrospective 
cohort
• Muscle-sparing free TRAM (n = 300)
• DIEP (n = 105)
X  Obese 
patients
2014 Benditte- 
Klepetko 
et al.
Netherlands Retrospective 
cohort
• Free TRAM (n = 22)
• DIEP (n = 18)
X   
2015 Weichman 
et al.
United States 
and Canada
Prospective 
cohort
• Pedicled TRAM (n = 83)
• Free TRAM (n = 91)
• DIEP (n = 296)
 X  
2015 Yang et al. China Cross- 
sectional
• Pedicled TRAM (n = 44)
• DIEP (n = 62)
 X  
2016 Knox et al. Canada Retrospective 
cohort
• Pedicled TRAM (n = 377)
• DIEP (n = 130)
X   
2016 Macadam 
et al.
United States 
and Canada
Retrospective 
cohort
• Pedicled TRAM (n = 683)
• Free TRAM (MS-0) (n = 144)
• Muscle-sparing free TRAM (n = 293)
• DIEP (n = 670)
X X  
2018 Erdmann-
Sager et al.
United States 
and Canada
Prospective 
cohort
• Pedicled TRAM (n = 89)
• Free TRAM (n = 115)
• DIEP (n = 445)
 X  
2018 Xu et al. China Prospective 
cohort
• Pedicled TRAM (n = 39)
• DIEP (n = 9)
X  Immediate, 
unilateral 
flaps
2019 Nelson et al. United States Prospective 
cohort
• Muscle-sparing free TRAM (n = 35)
• DIEP (n = 13)
X X  
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flap selection criteria based on complications and patient-
reported outcomes. Consistent with previous reports in 
the literature, we found a trend toward greater risk of 
abdominal bulge/hernia following pTRAM compared 
with DIEP flaps, reinforcing the notion that losing muscle 
makes abdominal fascia prone to weakness.4,5 Vascular 
complications, including flap loss and fat necrosis, also 
trend towards greater likelihood following pTRAM, sug-
gesting that tunneling a pedicled flap up to the chest com-
promises blood flow via kinking or compression of the 
superior epigastric vessels, or that the pedicle blood supply 
provides decreased perfusion.7,28,33 In contrast, DIEP flaps 
benefit from the enhanced blood supply of the inferior 
epigastric vessels or the flow dynamics from the internal 
mammary or thoracodorsal system. These relative risks are 
increased in low-volume hospitals, perhaps because low-
volume hospitals see patients with fewer comorbidities, for 
whom microsurgery is preferred.4,5 Another possibility is 
that because DIEP flap reconstructions have an increased 
mean surgical time and steeper learning curve,22 patients 
undergoing this procedure benefit from more careful 
intraoperative technique and postoperative monitoring. 
Albornoz et al. found that in higher-volume hospitals, 
where surgical technique benefits from greater experi-
ence,34 patients undergoing microvascular reconstruc-
tion were also less likely to experience complications than 
those undergoing autologous reconstructions in general.18 
Further studies examining the association between hospi-
tal volume and complication rates following abdominally-
based breast reconstruction, and differentiating between 
pTRAM, fTRAM, and DIEP flaps, are necessary to create 
flap-specific guidelines for improving safety.
There is a significantly greater risk of abdominal 
bulge/hernia following fTRAM compared to DIEP and 
Table 2. Pooled Complication Rates for pTRAM versus DIEP Flaps
Outcomes
Studies, 
N
 pTRAM DIEP
Effect 
Size
95%  
CI I2
No.  
Events
No.  
Patients
No.  
Events
No.  
Patients
Total or partial flap loss 6 90 1562 76 1233 1.03 −0.81 to 2.88 36.62%
 Low-volume hospitals only 4 22 774 17 505 1.15 −1.08 to 3.39 60.21%
Mastectomy skin flap necrosis 3 80 680 56 409 0.36 −1.39 to 2.11 0
 Low-volume hospitals only 2 69 483 34 192 0.86 −2.30 to 4.02 0
Fat necrosis (breast) 6 342 1667 210 1291 1.43 −0.33 to 3.18 90.50%
 Low-volume hospitals only 4 147 774 76 505 1.63 −0.53 to 3.80 93.00%
Infection (breast) 5 184 1457 93 1175 1.63 −0.36 to 3.62 86.59%
 Low-volume hospitals only 4 78 774 51 505 1.39 −0.87 to 3.65 77.24%
Hematoma/seroma (breast) 5 96 1468 105 1137 0.76 −1.21 to 2.73 30.37%
 Low-volume hospitals only 4 70 785 49 467 0.84 −1.39 to 3.07 0
Wound healing complications (breast) 4 97 774 29 505 1.49 −0.78 to 3.77 80.18%
 Low-volume hospitals only 3 91 577 23 288 1.64 −1.03 to 4.31 83.62%
Abdominal bulge/hernia 5 174 1100 74 1000 2.82 0.83 to 4.80 85.70%
 Low-volume hospitals only 3 55 312 15 272 3.08 0.46 to 5.70 48.08%
Wound healing complications (donor-site) 3 129 576 106 284 0.59 −1.86 to 3.04 0
 Low-volume hospitals only 2 120 471 94 226 0.68 −2.30 to 3.66 0
Table 3. Pooled Complication Rates for fTRAM versus DIEP Flaps
Outcomes
Studies, 
N
 DIEP fTRAM
Effect 
Size
95%  
CI I2
No.  
Events
No.  
Patients
No.  
Events
No.  
Patients
Total or partial flap loss 8 73 1083 50 1401 2.67 1.00 to 4.34 87.62%
 Without obese patients 7 68 978 45 1101 2.64 0.83 to 4.45 88.57%
 Muscle-sparing only 4 65 899 21 632 1.93 0.26 to 3.61 87.57%
   fTRAM  DIEP    
Outcomes
Studies, 
N
No.  
Events
No.  
Patients
No.  
Events
No.  
Patients
Effect 
Size
95%  
CI I2
Mastectomy skin flap necrosis 4 154 604 58 235 0.96 −1.31 to 3.28 0
 Without obese patients 3 28 304 8 130 1.03 −1.71 to 3.77 0
Fat necrosis (breast) 7 133 1430 143 1065 0.80 −0.83 to 2.44 0
 Without obese patients 6 125 1130 133 960 0.89 −0.88 to 2.66 0
 Muscle-sparing only 4 67 684 126 899 0.83 −1.32 to 2.98 0
Infection (breast) 5 63 1041 47 905 2.60 0.54 to 4.65 71.51%
 Without obese patients 4 51 741 44 800 2.93 0.61 to 5.26 78.60%
 Muscle-sparing only 2 42 560 45 364 2.10 −1.04 to 5.23 70.20%
Hematoma/seroma (breast) 5 55 1041 72 905 0.80 −1.20 to 2.80 15.91%
 Without obese patients 4 48 741 68 800 0.85 −1.40 to 3.10 36.80%
 Muscle-sparing only 2 25 560 41 364 0.43 −2.59 to 3.46 0
Wound healing complications, any (breast) 3 132 582 52 217 0.93 −1.74 to 3.59 0
 Without obese patients 2 6 282 2 112 0.96 −2.49 to 4.40 0
Abdominal bulge/hernia 9 94 1253 40 1030 2.87 1.73 to 4.00 70.48%
 Without obese patients 8 76 953 39 925 2.35 1.49 to 3.21 41.44%
 Muscle-sparing only 5 56 612 36 855 2.55 1.42 to 3.67 62.83%
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Fig. 2. Higher relative risk of abdominal bulge and hernia shown for ptraM and ftraM flaps compared 
with that for DieP flaps on meta-analysis, particularly for obese patients. the comparisons shown are (a) 
ptraM vs DieP, (b) ftraM vs DieP, (c) ftraM vs DieP subgroup analysis excluding 1 study using obese 
patients, and (d) MS ftraM vs DieP subgroup analysis. the horizontal lines represent the 95% confi-
dence intervals for each study.
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MS fTRAM flaps. Notably, relative to non-obese patients, 
obese patients experience a higher risk of abdominal 
bulge/hernia with fTRAM compared with DIEP flaps; so 
DIEP flaps should be performed in this population if pos-
sible. Obesity may increase the risk of abdominal bulge/
hernia following fTRAM flaps due to increased tension 
being placed on the weakened abdominal fascia.15 These 
healing problems may be mitigated following DIEP flaps, 
which leave less of an abdominal wall defect.35 Our find-
ings also indicate that muscle conservation increases the 
relative risk of flap loss. Therefore, DIEPs pose a greater 
risk of flap loss compared with MS fTRAM flaps, while 
fTRAM flaps pose the least risk. As fewer perforating ves-
sels are included with DIEP compared with free TRAM 
flaps, there is potential for less robust vascular supply.6,7
Studies reported significant differences in patient-
reported outcomes following TRAM and DIEP flap recon-
structions. Patients undergoing pTRAM flaps tended 
to report lower general satisfaction; lower physical well-
being, as measured by the BREAST-Q; and higher energy 
and emotional well-being, as measured by the SF-36. 
However, there were no differences in psychosocial and 
sexual well-being, or breast and aesthetic satisfaction. This 
indicates that although patients receiving pTRAM flap 
reconstruction have higher rates of abdominal morbidity 
and are less satisfied with their physical recovery process,12 
they are still ultimately satisfied with their aesthetic out-
come. They may even be more energetic and positive 
immediately postoperatively, following shorter operating 
times and lengths of stay.16,25,36 Thus, although free abdom-
inally based flaps have a more favorable complication pro-
file, pTRAM flaps may still be useful for certain patients, 
particularly when microsurgery is not an option secondary 
to surgeon expertise, comfort level or patient preference 
based on risk-weighted decisions. Patient-reported out-
comes following fTRAM, MS fTRAM, and DIEP flaps were 
similar, with the exception of higher BREAST-Q abdomi-
nal physical well-being scores in DIEP flaps compared with 
fTRAM flaps. This again suggests that while surgeons are 
highly concerned with donor-site morbidity, patients have 
a more holistic perspective toward well-being.
On the basis of these findings, we outline several rec-
ommendations for preoperative flap selection (Fig. 3). To 
decrease risk of abdominal bulge/hernia, muscle-sparing 
flaps (particularly DIEP, but also MS fTRAM flaps) should 
be considered before fTRAM among women who are 
appropriate microsurgical candidates, particularly those 
who are obese.13 Based on a previous meta-analysis, rais-
ing muscle-sparing flaps in obese patients may also have 
the additional benefit of lowering risk for flap loss and fat 
Table 4. Summary of Patient-Reported Outcomes Findings
Outcome Study
Direction of Finding
Statistical 
Adjustment MeasurepTRAM versus DIEP
fTRAM  
versus  
DIEP
MS  
fTRAM 
versus  
DIEP
Psychosocial 
outcomes
Chun et al., 2010 +   No SF-36 energy/fatigue
SF-36 emotional well-being
Macadam et al., 
2016
= = = Yes BREAST-Q psychosocial well-being
BREAST-Q sexual well-being
Erdmann-Sager  
et al., 2018
= =  Yes BREAST-Q psychosocial well-being
BREAST-Q sexual well-being
Nelson et al., 2019   = No SF-36 mental health composite
Satisfaction Momoh et al., 2012 General satisfaction: -
Aesthetic satisfaction: =
  No MBROS general satisfaction
MBROS aesthetic satisfaction
Yang et al., 2015 =   No MBROS general satisfaction
MBROS aesthetic satisfaction
Macadam et al., 
2016
Satisfaction breasts: =
Satisfaction outcome: -
= = Yes BREAST-Q satisfaction breasts
BREAST-Q satisfaction outcome
Erdmann-Sager  
et al., 2018
= =  Yes BREAST-Q satisfaction breasts
Physical 
well-being
Schaverien et al., 
2007
 =  No SF-36 physical functioning
SF-36 physical role limitations
Weichman et al., 
2015
= =  Yes BREAST-Q PWB chest
Macadam et al., 
2016
- = = Yes BREAST-Q PWB abdomen
Erdmann-Sager  
et al., 2018
PWB chest (one year): =
PWB chest (two year): -
PWB abdomen: -
PWB chest: =
PWB abdomen: -
 Yes BREAST-Q PWB chest
BREAST-Q PWB abdomen
Nelson et al., 2019   = No BREAST-Q PWB abdomen
SF-36 physical health composite
Pain Schaverien et al., 
2007
 =  No SF-36 pain
Bold entries indicate the studies finding statistically significant differences in patient-reported outcome scores between flaps (i.e. the direction of finding is either 
+ or -).
+ score for first reconstruction technique higher than score for second reconstruction technique.
- score for second reconstruction technique higher than score for first reconstruction technique.
= scores equivalent for both reconstruction techniques.
SF-36, short-form 36; MBROS, Michigan Breast Reconstruction Outcome Study.
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necrosis.16 Our findings with regard to DIEP flaps in obese 
patients contrast with conventional recommendations, 
suggesting that TRAM flaps should be raised for obese 
patients.27,29 Additionally, given higher rates of abdominal 
morbidity, the use of synthetic mesh for fascial closure 
may have particular utility in obese patients and should be 
investigated in future work.37,38 To prevent vascular com-
plications such as flap loss, planned DIEP and MS fTRAM 
flap reconstructions should be converted to fTRAM flaps 
if surgeons are unable to identify perforators greater 
than 1.5 mm in the same intermuscular septum.11,23,26,27,29 
If microsurgical breast reconstruction is unavailable or if 
the patient is too unstable to undergo a prolonged opera-
tion, pTRAM flaps should be performed despite the trend 
toward an increased risk of flap-related and abdominal 
morbidity. Finally, while this review does not explore non-
clinical patient characteristics such as preoperative activity 
level, it is important to remember that patient goals are 
vital to the flap selection process. For example, a woman 
who desires less fatigue and emotional toll during recov-
ery may opt to pursue pTRAM flap reconstruction despite 
the increased risk of abdominal morbidity.16,25,36
Because the current literature is limited by a lack of ran-
domized controlled trials and because patients undergo-
ing different flap reconstruction techniques are often not 
equivalent surgical candidates, it is particularly important 
for cohort studies to report patient demographic, clinical, 
and treatment characteristics as well as to use analysis meth-
ods that control for these characteristics. Yet more than 
half of the included studies were characterized by a moder-
ate or severe bias due to confounding (see Supplemental 
Digital Content 1, http://links.lww.com/PRSGO/B491). 
Our statistical analysis attempted to control for obesity and 
hospital procedure volume status, and our findings regard-
ing complication rates are consistent with those reported 
by consortium and national database studies,10,39,40 which 
are less likely to be biased by single-surgeon and hospital 
factors. Due to a lack of extractable data, we were unable 
to control for other preoperative risk factors. More high-
quality, prospective cohort studies are therefore needed to 
demonstrate how additional patient characteristics impact 
complication rates and patient well-being.
The lack of standardization in flap harvest techniques 
creates another potential source of bias. Due to surgeon-
specific variations in technique, MS fTRAM flaps at one 
institution may be coded as DIEP flaps at another insti-
tution, thereby confounding the results. This review 
demonstrates that increased muscle harvest is associated 
with increased relative risk of abdominal bulge/hernia 
and other complications. However, several studies do not 
Fig. 3. Higher relative risk of total and partial flap loss shown for DieP flaps compared with ftraM flaps on meta-analysis. the comparisons 
shown are (a) DieP vs ftraM and (b) DieP vs MS ftraM subgroup analysis.
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report which degree of muscle-sparing surgery they per-
form during MS fTRAM flap reconstruction.9,13,14,23,26,27 
As muscle-sparing flap harvest techniques become more 
popular and new variations are developed,41 for the sake 
of accurate outcomes reporting and patient counseling, 
it is increasingly important for surgeons to adhere to a 
uniform classification system of muscle wall preservation. 
DellaCroce et al. has expanded on the traditional clas-
sification system by offering a specific definition for the 
point at which muscle transection in the DIEP flap harvest 
equates to a muscle-sparing fTRAM flap.
The use of the abdominal wall for autologous breast 
reconstruction is an optimized procedure for both aes-
thetic and functional outcomes. Our findings demon-
strate that complications and patient-reported outcomes 
following abdominally based breast reconstruction tech-
niques depend on flap type as well as patient- (ie, obe-
sity) and hospital-level factors (ie, procedure volume). 
When possible, DIEP and MS fTRAM reconstructions 
should be performed for obese patients to decrease risk 
of abdominal bulge/hernia. Although pTRAM flaps are 
associated with a greater risk of complications, particu-
larly in low-volume hospitals, they may still be an appro-
priate option when microsurgery is not available. When 
selecting the appropriate abdominally based flap type for 
autologous breast reconstruction, surgeon expertise must 
be balanced with patient preferences, and risks of flap- 
and donor-site morbidity must be weighed with patient 
wishes and comorbidities. This systematic review is a use-
ful guide that will inform both patient and provider in the 
shared decision-making process. Maintaining transpar-
ency regarding potential safety and satisfaction outcomes 
will allow these discussions to take place in an open and 
honest manner.
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St. Louis, MO 63110 
E-mail: jmsacks@wustl.edu
ACKNOWLEDGMENT
We thank Stella Seal, MLS, for her assistance in developing 
and conducting a search strategy.
REFERENCES
 1. American Society of Plastic Surgeons. 2018 Plastic Surgery 
Statistics Report. 2018. Available at https://www.plasticsurgery.
org/documents/News/Statistics/2018/plastic-surgery-statistics-
full-report-2018.pdf.
 2. Marra A, Viale G, Pileri SA, et al. Breast implant-associated ana-
plastic large cell lymphoma: a comprehensive review. Cancer Treat 
Rev. 2020;84:101963. 
 3. U.S. Food & Drug Administration. Breast Implants – Certain 
Labeling Recommendations to Improve Patient Communication. 
2019. Available at https://www.fda.gov/regulatory-information/
search-fda-guidance-documents/breast-implants-certain-label-
ing-recommendations-improve-patient-communication.
 4. Egeberg A, Rasmussen MK, Sørensen JA. Comparing the donor-
site morbidity using DIEP, SIEA or MS-TRAM flaps for breast 
reconstructive surgery: a meta-analysis. J Plast Reconstr Aesthet 
Surg. 2012;65:1474–1480. 
 5. Atisha D, Alderman AK. A systematic review of abdominal wall 
function following abdominal flaps for postmastectomy breast 
reconstruction. Ann Plast Surg. 2009;63:222–230. 
 6. Sailon AM, Schachar JS, Levine JP. Free transverse rectus abdom-
inis myocutaneous and deep inferior epigastric perforator flaps 
for breast reconstruction: a systematic review of flap complication 
rates and donor-site morbidity. Ann Plast Surg. 2009;62:560–563. 
 7. Kroll SS. Fat necrosis in free transverse rectus abdominis myo-
cutaneous and deep inferior epigastric perforator flaps. Plast 
Reconstr Surg. 2000;106:576–583. 
 8. Mulvey CL, Cooney CM, Daily FF, et al. Increased flap weight and 
decreased perforator number predict fat necrosis in DIEP breast 
reconstruction. Plast Reconstr Surg Glob Open. 2013;1:1–7. 
 9. Macadam SA, Zhong T, Weichman K, et al. Quality of life and 
patient-reported outcomes in breast cancer survivors: a multi-
center comparison of four abdominally based autologous recon-
struction methods. Plast Reconstr Surg. 2016;137:758–771. 
 10. Erdmann-Sager J, Wilkins EG, Pusic AL, et al. Complications and 
patient-reported outcomes after abdominally based breast recon-
struction: results of the Mastectomy Reconstruction Outcomes 
Consortium Study. Plast Reconstr Surg. 2018;141:271–281. 
Fig. 4. evidence-based decision-making algorithm for abdominally based breast reconstruction options (ie, ptraM, ftraM, MS ftraM, 
and DieP flaps).
PRS Global Open • 2020
10
 11. Schaverien MV, Perks AG, McCulley SJ. Comparison of out-
comes and donor-site morbidity in unilateral free TRAM ver-
sus DIEP flap breast reconstruction. J Plast Reconstr Aesthet Surg. 
2007;60:1219–1224. 
 12. Weichman KE, Hamill JB, Kim HM, et al. Understanding the 
recovery phase of breast reconstructions: patient-reported out-
comes correlated to the type and timing of reconstruction. J Plast 
Reconstr Aesthet Surg. 2015;68:1370–1378. 
 13. Fischer JP, Nelson JA, Sieber B, et al. Free tissue transfer in 
the obese patient: an outcome and cost analysis in 1258 con-
secutive abdominally based reconstructions. Plast Reconstr Surg. 
2013;131:681e–692e. 
 14. Nelson JA, Tecci MG, Lanni MA, et al. Function and strength 
after free abdominally based breast reconstruction: a 10-year 
follow-up. Plast Reconstr Surg. 2019;143:22e–31e. 
 15. Chang D, Wang B, Robb G, et al. Effect of obesity on flap and 
donor-site complications in free transverse rectus abdominis 
myocutaneous flap breast reconstruction. Plast Reconstr Surg. 
2002;105:1199–1200. 
 16. Lee KT, Mun GH. Effects of obesity on postoperative complica-
tions after breast reconstruction using free muscle-sparing trans-
verse rectus abdominis myocutaneous, deep inferior epigastric 
perforator, and superficial inferior epigastric artery flap: a system-
atic review and meta-analysis. Ann Plast Surg. 2016;76:576–584. 
 17. Chattha A, Chen AD, Muste J, et al. Revisiting the relation-
ship between hospital case volume and outcomes in abdomi-
nally based free flap breast reconstruction. Ann Plast Surg. 
2020;85:397–401. 
 18. Albornoz CR, Cordeiro PG, Hishon L, et al. A nationwide analysis 
of the relationship between hospital volume and outcome for autol-
ogous breast reconstruction. Plast Reconstr Surg. 2013;132:192–200. 
 19. Billig JI, Lu Y, Momoh AO, et al. A nationwide analysis of cost 
variation for autologous free flap breast reconstruction. JAMA 
Surg. 2017;152:1039–1047. 
 20. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for 
assessing risk of bias in non-randomised studies of interventions. 
BMJ. 2016;355:i4919. 
 21. Benditte-Klepetko HC, Lutgendorff F, Kästenbauer T, et al. Analysis 
of patient satisfaction and donor-site morbidity after different types 
of breast reconstruction. Scand J Surg. 2014;103:249–255. 
 22. Knox AD, Ho AL, Leung L, et al. Comparison of outcomes fol-
lowing autologous breast reconstruction using the DIEP and 
pedicled TRAM flaps: a 12-year clinical retrospective study and 
literature review. Plast Reconstr Surg. 2016;138:16–28. 
 23. Nelson JA, Guo Y, Sonnad SS, et al. A Comparison between 
DIEP and muscle-sparing free TRAM flaps in breast reconstruc-
tion: a single surgeon’s recent experience. Plast Reconstr Surg. 
2010;126:1428–1435. 
 24. Chen CM, Halvorson EG, Disa JJ, et al. Immediate postoperative 
complications in DIEP versus free/muscle-sparing TRAM flaps. 
Plast Reconstr Surg. 2007;120:1477–1482. 
 25. Chun YS, Sinha I, Turko A, et al. Comparison of morbidity, func-
tional outcome, and satisfaction following bilateral TRAM ver-
sus bilateral DIEP flap breast reconstruction. Plast Reconstr Surg. 
2010;126:1133–1141. 
 26. Nahabedian MY, Tsangaris T, Momen B. Breast reconstruction 
with the DIEP flap or the muscle-sparing (MS-2) free TRAM flap: 
is there a difference? Plast Reconstr Surg. 2005;115:436–444; dis-
cussion 445. 
 27. Bajaj AK, Chevray PM, Chang DW. Comparison of donor-site 
complications and functional outcomes in free muscle-sparing 
TRAM flap and free DIEP flap breast reconstruction. Plast 
Reconstr Surg. 2006;117:737–746; discussion 747. 
 28. Garvey PB, Buchel EW, Pockaj BA, et al. DIEP and pedicled 
TRAM flaps: a comparison of outcomes. Plast Reconstr Surg. 
2006;117:1711–1719; discussion 1720. 
 29. Nahabedian MY, Momen B, Galdino G, et al. Breast reconstruc-
tion with the free TRAM or DIEP flap: patient selection, choice 
of flap, and outcome. Plast Reconstr Surg. 2002;110:466–475; dis-
cussion 476. 
 30. Xu F, Sun H, Zhang C, et al. Comparison of surgical complica-
tion between immediate implant and autologous breast recon-
struction after mastectomy: a multicenter study of 426 cases. J 
Surg Oncol. 2018;118:953–958. 
 31. Yang B, Li L, Yan W, et al. The type of breast reconstruction may 
not influence patient satisfaction in the Chinese population: a 
single institutional experience. PLoS One. 2015;10:1–11. 
 32. Momoh AO, Colakoglu S, Westvik TS, et al. Analysis of compli-
cations and patient satisfaction in pedicled transverse rectus 
abdominis myocutaneous and deep inferior epigastric perfora-
tor flap breast reconstruction. Ann Plast Surg. 2012;69:19–23. 
 33. Schusterman MA, Kroll SS, Weldon ME. Immediate breast recon-
struction: why the free TRAM over the conventional TRAM flap? 
Plast Reconstr Surg. 1992;90:255–261. 
 34. Hallock GG. Is there a “learning curve” for muscle perforator 
flaps? Ann Plast Surg. 2008;60:146–149. 
 35. Garvey PB, Buchel EW, Pockaj BA, et al. The deep inferior epi-
gastric perforator flap for breast reconstruction in overweight 
and obese patients. Plast Reconstr Surg. 2005;115:447–457. 
 36. Holoyda KA, Simpson AM, Ye X, et al. Immediate bilateral breast 
reconstruction using abdominally based flaps: an analysis of 
the nationwide inpatient sample database. J Reconstr Microsurg. 
2019;35:594–601. 
 37. Banic A, Boeckx W, Greulich M, et al. Late results of breast 
reconstruction with free TRAM flaps: a prospective multicentric 
study. Plast Reconstr Surg. 1995;95:1195–1204; discussion 1205.
 38. Rossetto LA, Abla LE, Vidal R, et al. Factors associated with her-
nia and bulge formation at the donor site of the pedicled TRAM 
flap. Eur J Plast Surg. 2010;33:203–208. 
 39. Shubinets V, Fox JP, Sarik JR, et al. Surgically treated hernia 
following abdominally based autologous breast reconstruction: 
prevalence, outcomes, and expenditures. Plast Reconstr Surg. 
2016;137:749–757. 
 40. Wilkins EG, Hamill JB, Kim HM, et al. Complications in postmas-
tectomy breast reconstruction. Ann Surg. 2018;267:164–170. 
 41. DellaCroce FJ, DellaCroce HC, Blum CA, et al. Myth-busting 
the DIEP flap and an introduction to the abdominal perfora-
tor exchange (APEX) breast reconstruction technique: a sin-
gle-surgeon retrospective review. Plast Reconstr Surg. 2019;143: 
992–1008. 
